Neuroprotective Research Dopaminergic System Protection Multiple studies have demonstrated BPC-157's ability to protect dopaminergic neurons from various toxins, including [18]: MPTP (a toxin used to model Parkinson's disease) Amphetamine-induced neurotoxicity Haloperidol-induced catalepsy Peripheral Nerve Healing Research by Gjurasin et al
It provides a preserved aqueous vehicle that can be accessed multiple times, making it useful for reconstituting lyophilized research peptides and preparing small-volume stock solutions in laboratory workflows
BPC 157 therapy also, on its own, counteracts isoniazid (GABA synthesis inhibitor)-, picrotoxin (non-completive channel blocker for GABAA receptors (GABAARs) chloride channels)- [58], and bicuculline (completive antagonists of GABAARs)-convulsions [15]
Coxsackievirus B3 proteins directionally complement each other to downregulate surface major histocompatibility complex class I
We use Methylcobalamin vitamin B12, which is the most bio-available (this means its absorbed by the body easier), which is also non-prescription
However, it's important to note that despite its prospects as an injectable treatment, GHK-Cu's systemic effects are only supported by animal and in vitro studies